Nabla Secures $70M Series C to Enhance Clinical AI

Nabla has raised $70 million in Series C funding, bringing its total funding to $120 million, announced in a press release. The funding round was led by HV Capital, with participation from Highland Europe, DST Global, and existing investors Cathay Innovation and Tony Fadell's Build Collective.

The new capital will accelerate the development of Nabla's AI assistant, which is designed to optimize clinical and financial workflows in healthcare settings. Nabla's AI is currently used by over 130 healthcare organizations and 85,000 clinicians, supporting a wide range of clinical roles and delivering measurable ROI across workflows.

Nabla plans to expand its AI assistant's capabilities to include coding, agentic EHR commands, and support for diverse clinical roles. The platform integrates with major EHR systems and is available in 35 languages, aiming to enhance efficiency and reduce clinician burnout by cutting documentation time significantly.

The company is also focusing on building a comprehensive Adaptive Agentic Platform, which will include features like a Proactive Coding Agent and a Context-Aware Agent to improve real-time support and documentation processes. Nabla's growth strategy includes expanding into new care settings and forming strategic partnerships to deliver impact on a national scale.